Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
#2828 G3 Neuroendocrine Tumours and Carcinomas: Clinicopathological Features for Distinct Entities
Introduction: The 2019 WHO subclassified the grade 3 (G3) gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) into neuroendocrine carcinoma (NEC) or tumors (G3 NET). Yet, few data exist on clinical and treatment profiles for G3 NET.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Taboada R
Authors: Taboada R, Claro L, Campos F, Felismino T, de Jesus V,
Keywords: neuroendocrine, high grade, clinicopathological, carcinoma, G3,
#2201 Early Prognostic Factors in Medullary Thyroid Carcinoma
Introduction: Medullary thyroid carcinoma (MTC) prognosis has been related with several variables, being calcitonin doubling time one of the most important prognostic factor. However, it is not evaluable in the early postoperative period.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Muñoz de Nova J, Di Martino M, Marín Campos C, Lahera Vargas M, Mora Guzmán I,
Keywords: medullary thyroid carcinoma, thyroid surgery, prognosis,
#1179 A Phase II Study of Axitinib in Advanced Carcinoid Tumors: Preliminary Results
Introduction: NETs are highly vascularized neoplasms overexpressing VEGF as well as VEGFR. Axitinib is a TKI with selective picomolar potency against VEGFR-1, -2 and -3
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author:
Authors: Cives M, Strosberg J, Campos T, Weber T, Nickerson M,
Keywords: axitinib, anti-angiogenesis, VEGFR,
Introduction: Hepatic transarterial embolization is often recommended for patients with liver-predominant metastatic NETs. Antiangiogenic therapy following embolization may delay tumor revascularization.
Conference: 8th Annual ENETSConcerence (2011)
Presenting Author:
Authors: Strosberg J, Cheema A, Campos T, Kvols L,
Keywords: transarterial embolization, sunitinib, progression-free survival,